Zerlauth G, Eibl M M, Mannhalter J W
Department of Immunological Research, Immuno, Vienna, Austria.
Clin Exp Immunol. 1991 Jul;85(1):90-7. doi: 10.1111/j.1365-2249.1991.tb05688.x.
The requirements for activation of anti-mycobacterial and anti-listerial activity of human monocytes were investigated. Human monocytes could be activated to display enhanced anti-mycobacterial activity by a 24-h treatment with lipopolysaccharide. The mediator induced by this treatment was identified as being tumour necrosis factor-alpha (TNF-alpha). Addition of recombinant TNF-alpha (rTNF-alpha) to the cultures of human monocytes for 24 h yielded comparable results (minimal dose required for induction of anti-mycobacterial activity, 10 U ml). Addition of anti-TNF-alpha antibody completely abrogated the effect. A similar treatment protocol failed to activate enhanced anti-listerial activity. To trigger anti-listerial activity, sequential treatment of human monocytes with rTNF-alpha and IL-2 was required. Treatment of monocytes with 10 U ml rTNF-alpha for 24 h followed by incubation in the presence of 200 U/ml of IL-2 for an additional 24 h yielded a reduction of listerial growth which was moderate but statistically significant (P less than 0.001). The activation of monocytes observed with rTNF-alpha/IL-2 treatment was (i) dependent on both cytokines; (ii) sequence dependent (i.e. when IL-2 was added prior to rTNF-alpha, no effect was observed); and (iii) absent in cells treated with one cytokine only. Enhancement of anti-listerial activity by sequential use of cytokines was not accompanied by an increase in oxidative burst, which indicated that oxidative mechanisms were not the reason for the observed Listeria monocytogenes growth restriction. Further support for this hypothesis was obtained after interferon-gamma treatment of human monocytes which led to an augmented PMA-inducible release of active oxygen radicals, but was not paralleled by growth restriction of L. monocytogenes. Our results indicate that TNF-alpha plays a crucial role in the activation of monocytes for growth restriction of intracellular microbes. Activation of human monocytes to restrict the growth of the facultative intracellular bacteria Mycobacterium avium intracellulare and L. monocytogenes, however, follows different patterns, the initial trigger in both cases being provided by TNF-alpha-induced signals.
研究了人单核细胞激活抗分枝杆菌和抗李斯特菌活性的条件。用脂多糖处理人单核细胞24小时,可激活其显示出增强的抗分枝杆菌活性。该处理诱导的介质被鉴定为肿瘤坏死因子-α(TNF-α)。向人单核细胞培养物中添加重组TNF-α(rTNF-α)24小时产生了类似的结果(诱导抗分枝杆菌活性所需的最小剂量为10 U/ml)。添加抗TNF-α抗体完全消除了该效应。类似的处理方案未能激活增强的抗李斯特菌活性。为了触发抗李斯特菌活性,需要用人单核细胞依次用rTNF-α和IL-2处理。用10 U/ml rTNF-α处理单核细胞24小时,然后在200 U/ml IL-2存在下再孵育24小时,导致李斯特菌生长减少,虽程度适中但具有统计学意义(P小于0.001)。用rTNF-α/IL-2处理观察到的单核细胞激活具有以下特点:(i)依赖于两种细胞因子;(ii)依赖顺序(即当在rTNF-α之前添加IL-2时,未观察到效应);(iii)仅用一种细胞因子处理的细胞中不存在。依次使用细胞因子增强抗李斯特菌活性并未伴随氧化爆发增加,这表明氧化机制不是观察到的单核细胞增生李斯特菌生长受限的原因。在用人单核细胞进行干扰素-γ处理后获得了对该假设的进一步支持,该处理导致佛波酯诱导的活性氧自由基释放增加,但并未伴随单核细胞增生李斯特菌的生长受限。我们的结果表明,TNF-α在激活单核细胞以限制细胞内微生物生长中起关键作用。然而,激活人单核细胞以限制兼性细胞内细菌鸟分枝杆菌和单核细胞增生李斯特菌的生长遵循不同模式,在这两种情况下,初始触发均由TNF-α诱导的信号提供。